PT Darya-Varia Laboratoria Tbk (IDX: DVLA)

Market Cap	1.83T
Revenue (ttm)	2.13T
Net Income (ttm)	193.91B
Shares Out	1.12B
EPS (ttm)	173.13
PE Ratio	9.41
Forward PE	n/a
Dividend	108.00 (6.63%)
Ex-Dividend Date	Nov 1, 2024

Volume	21,500
Open	1,630.00
Previous Close	1,630.00
Day's Range	1,615.00 - 1,635.00
52-Week Range	1,375.00 - 1,850.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About DVLA

PT Darya-Varia Laboratoria Tbk engages in the manufacture and trading of pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company provides prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women healthcare, antiparasit, vitamin and food supplements, anti fungal, plastic surgery, general surgery, burn, trauma wound, aesthetic me...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1976
• Employees: 1,269
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: DVLA

Financial Performance

In 2023, DVLA's revenue was 1.89 trillion, a decrease of -1.36% compared to the previous year's 1.92 trillion. Earnings were 146.34 billion, a decrease of -2.03%.